Surgical valve interventions are performed primarily in patients with severe valve heart disease, with associated symptoms and/or anatomical/hemodynamic consequences, and no contraindication to the procedure. The choice of prosthetic valve should be based on a shared decision-making process that must account for the trade-offs between durability (and the need for reintervention), bleeding, and thromboembolism. The manuscript: “Late Outcomes of Aortic Valve Replacement with Bioprosthesis and Mechanical Prosthesis” is an observational retrospective study intended to evaluate the long-term follow-up of patients […]